Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Canada News Beep | NewsBeep.com
Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

treatment options

6 posts
MMedication
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Read More

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

  • August 19, 2026
Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…
HHealthcare
WHO warns global cancer cases could nearly double by 2050
Read More

WHO warns global cancer cases could nearly double by 2050

  • July 8, 2026
The World Health Organization (WHO) said on Wednesday that the number of new cancer cases diagnosed worldwide each…
HHealth
Cancer jab eradicates entire tumours in breakthrough trial
Read More

Cancer jab eradicates entire tumours in breakthrough trial

  • May 30, 2026
Medical experts are hailing “unprecedentedly strong responses” to an injection that eradicated entire tumours in otherwise treatment-resistant cancer…
MMedication
What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
Read More

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

  • February 6, 2026
Hims An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,…
MMedication
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
Read More

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

  • December 9, 2025
Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target…
HHealth
United Press International
Read More

Report: Nitrous oxide found effective as major depression treatment

  • December 1, 2025
Nov. 30 (UPI) — Results of a new study show that patients with major depressive order who have…
Canada News Beep | NewsBeep.com
www.newsbeep.com